Production (Stage)
Harvard Bioscience, Inc.
HBIO
$0.3733
$0.037111.04%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 21.77M | 24.56M | 21.97M | 23.10M | 24.51M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 21.77M | 24.56M | 21.97M | 23.10M | 24.51M |
Cost of Revenue | 9.59M | 10.50M | 9.21M | 9.88M | 9.74M |
Gross Profit | 12.18M | 14.05M | 12.77M | 13.22M | 14.77M |
SG&A Expenses | 10.16M | 10.01M | 10.56M | 11.08M | 11.87M |
Depreciation & Amortization | 1.16M | 1.26M | 1.33M | 1.33M | 1.33M |
Other Operating Expenses | 171.00K | 0.00 | -- | -147.00K | 966.00K |
Total Operating Expenses | 23.40M | 24.10M | 23.67M | 24.77M | 26.79M |
Operating Income | -1.62M | 459.00K | -1.70M | -1.67M | -2.28M |
Income Before Tax | -50.79M | 590.00K | -4.49M | -3.28M | -4.48M |
Income Tax Expenses | -454.00K | 572.00K | 311.00K | -353.00K | 210.00K |
Earnings from Continuing Operations | -50.34M | 18.00K | -4.80M | -2.93M | -4.69M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -50.34M | 18.00K | -4.80M | -2.93M | -4.69M |
EBIT | -1.62M | 459.00K | -1.70M | -1.67M | -2.28M |
EBITDA | 31.00K | 2.22M | 120.00K | 128.00K | -498.00K |
EPS Basic | -1.14 | 0.00 | -0.11 | -0.07 | -0.11 |
Normalized Basic EPS | -0.04 | 0.04 | -0.06 | -0.04 | -0.05 |
EPS Diluted | -1.14 | 0.00 | -0.11 | -0.07 | -0.11 |
Normalized Diluted EPS | -0.04 | 0.03 | -0.06 | -0.04 | -0.05 |
Average Basic Shares Outstanding | 44.10M | 43.66M | 43.61M | 43.49M | 43.40M |
Average Diluted Shares Outstanding | 44.10M | 44.45M | 43.61M | 43.49M | 43.40M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |